Jamjoom Pharmaceuticals Factory Co (SAU:4015) Total Liabilities : ﷼281 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Jamjoom Pharmaceuticals Factory Co Total Liabilities?

Jamjoom Pharmaceuticals Factory Co's Total Liabilities for the quarter that ended in Dec. 2024 was ﷼281 Mil.

Jamjoom Pharmaceuticals Factory Co's quarterly Total Liabilities increased from Jun. 2024 (﷼351.44 Mil) to Sep. 2024 (﷼412.83 Mil) but then declined from Sep. 2024 (﷼412.83 Mil) to Dec. 2024 (﷼281.03 Mil).

Jamjoom Pharmaceuticals Factory Co's annual Total Liabilities increased from Dec. 2022 (﷼191.55 Mil) to Dec. 2023 (﷼249.84 Mil) and increased from Dec. 2023 (﷼249.84 Mil) to Dec. 2024 (﷼281.03 Mil).

Jamjoom Pharmaceuticals Factory Co Total Liabilities Historical Data

The historical data trend for Jamjoom Pharmaceuticals Factory Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jamjoom Pharmaceuticals Factory Co Total Liabilities Chart

Jamjoom Pharmaceuticals Factory Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

316.59

200.66

191.55

249.84

281.03

Jamjoom Pharmaceuticals Factory Co Quarterly Data
	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial										249.84	299.40	351.44	412.83	281.03

Jamjoom Pharmaceuticals Factory Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Jamjoom Pharmaceuticals Factory Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	201.764	+	(1.833	+	-2.8421709430404E-14
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	77.43	+	0)
	=	281

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	1771.635	-	1490.608
	=	281

Jamjoom Pharmaceuticals Factory Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	201.764	+	(1.833	+	-2.8421709430404E-14
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	77.43	+	0)
	=	281

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	1771.635	-	1490.608
	=	281

Jamjoom Pharmaceuticals Factory Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Jamjoom Pharmaceuticals Factory Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jamjoom Pharmaceuticals Factory Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jamjoom Pharmaceuticals Factory Co (SAU:4015) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box No. 6267, Jeddah, SAU, 21442

Website

https://www.jamjoompharma.com

Jamjoom Pharmaceuticals Factory Co is engaged in the development, manufacture, and marketing of a wide range of high-quality branded generic pharmaceuticals, including pharmaceuticals and consumer health products, with the majority of revenue coming from pharmaceutical sales. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.

Jamjoom Pharmaceuticals Factory Co Headlines

No Headlines